Mickelson Announcement Prompts Expedited Filing Of Psoriasis Research Plan With FDA By Energex Systems, Inc.

Links shared publicly online about this topic.

  • 936
    total visits

Mickelson Announcement Prompts Expedited Filing Of Psoriasis Research Plan With FDA By Energex Systems, Inc.

medicalnewstoday.com

A research plan that is designed to determine the degree of effectiveness of an experimental non-drug therapy known as ImmunoModulation for the treatment of psoriasis as a primary indication and p

View full resource at medicalnewstoday.com

Tags: Dermatology, Psoriasis, FDA

  • Share

Most Recently Shared on August 19, 2010 at 4:59 pm By:

Psoriasis_OW Psoriasis OW

Mickelson Announcement Prompts Expedited Filing Of Psoriasis Research Plan With FDA By Energex Systems, Inc.: A re... http://mnt.to/f/3Hyt

2 years ago...

Also Shared By:

MNT Dermatology News MNT Dermatology News

MNT Eczema News MNT Eczema News

Mickelson Announcement Prompts Expedited Filing of Psoriasis Research Plan with FDA by Energex Systems, Inc. | Business Wire

businesswire.com — “ALLENDALE, N.J.--(BUSINESS WIRE)--A research plan that is designed to determine the degree of effectiveness of an experimental non-drug therapy known as ImmunoModulation for the treatment of psoriasis as a primary indication and psoriatic arthritis as a secondary indication, will be filed with the Federal Food and Drug Administration in an expedited manner. In a letter that was delivered to the FDA today, medical technology developer Energex Systems, Inc. requested a Pre – Investigational View full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on August 17, 2010 at 10:56 pm By:

Psoriasis_OW Psoriasis OW OW Health

Mickelson Announcement Prompts Expedited Filing of Psoriasis Research Plan with FDA by Energex Systems, Inc.: ALLE... http://bit.ly/bo8sfi

2 years ago...

Advertisement